DOJ Continues to Discuss Updates to Compliance Program Guidance and Corporate Enforcement Policies
Sheppard Mullin – At the Food and Drug Law Institute’s Annual Conference in May, the DOJ’s Consumer Protection Branch and the FDA discussed each agency’s approach to the CPB’s new Voluntary Self-Disclosure Policy for Business Organizations.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.